DOI: https://doi.org/10.22141/2224-0713.7.77.2015.78131

Quality of Life in Patients with Multiple Sclerosis: Therapeutic Effect of Cholecalciferol (Vitamin D3)

S.L. Malyk, S.P. Moskovko, H.S. Moskovko, N.V. Tytarenko

Abstract


The objective of this study was to investigate the likely impact of the annual course of compensation for 25(OH)D metabolism deficiency using officinal preparation of vitamin D on the quality of life of patients with multiple sclerosis. We have analyzed the observation data of 57 patients with multiple sclerosis. After 1 year, in vitamin D3 group a significant increase has been determined in terms of the assessment of the general perception of health (p = 0.002), vitality (p = 0.003), role of the emotional problems in disability (p = 0.01), indicator of mental health (p = 0.008). The use of vitamin D3 had a positive impact on the mental component of quality of life.


Keywords


multiple sclerosis; quality of life; cholecalciferol (vitamin D3); SF-36

References


Костюченко А.В. Коморбідність і якість життя при множинному склерозі / А.В. Костюченко // Укр. науково-медичний молодіжний журнал. — 2011. — № 1. — С. 303.

Соколова Л.И. Влияние депрессии и тревожности на качество жизни больных рассеянным склерозом / Л.И. Соколова, А.В. Гудзенко // Укр. неврол. журн. — 2011. — № 1(18). — С. 47-51.

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis / M. Soilu-Hänninen, J. Aivo, B.M. Lindström et al. // J. Neurol. Neurosurg. Psychiatry. — 2012. — Vol. 83, № 5. — Р. 565-571.

Cumulative impact of comorbidity on quality of life in MS / R.A. Marrie, R. Horwitz, G. Cutter, T. Tyry // Acta Neurol. Scand. — 2012. — Vol. 125, № 3. — Р. 180-186.

Dietary intake of vitamin D during adolescence and risk of multiple sclerosis / K.L. Munger, T. Chitnis, A.L. Frazier et al. // J. Neurol. — 2011. — Vol. 258, № 3. — Р. 479-485.

Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial / M. Kjaergaard, K. Waterloo, C.E. Wang et al. // Br. J. Psychiatry. — 2012. — Vol. 201, № 5. — Р. 360-368.

Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study / F. Patti, A. Pappalardo, E. Montanari et al. // J. Neurol. Sci. — 2014. — Vol. 337, № 1–2. — Р. 180-185.

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis / T.F. Runia, W.C. Hop, Y.B. de Rijke et al. // Neurology. — 2012. — Vol. 79, № 3. — Р. 261-266.

Quality of life and its assessment in multiple sclerosis: integrating physical and psychological compon / A.J. Mitchell, J. Benito-Leon, J.M. Gonzalez, J. Rivera-Navarro // Lancet Neurol. — 2005. — Vol. 4, № 9. — Р. 556-566.

Quality of life in multiple sclerosis: effects of current treatment options / O. Kargiotis, A. Paschali, L. Messinis, P. Papathanasopoulos // Int. Rev. Psychiatry. — 2010. — Vol. 22, № 1. — P. 67-82.

Quality of life in multiple sclerosis-association with clinical features, fatigue and depressive syndrome / B. Łabuz-Roszak, K. Kubicka-Baczyk, K. Pierzchała et al. // J. Psychiatr. Pol. — 2013. — Vol. 47, № 3. — Р. 433-442.

Quality of life in patients with multiple sclerosis / V.B. Kes, L. Čengić, M. Cesarik et al. // Acta Clin. Croat. — 2013. — Vol. 52, № 1. — Р. 107-111.

Sleep Disorders Reduce Health-Related Quality of Life in Multiple Sclerosis (Nottingham Health Profile Data in Patients with Multiple Sclerosis) / C. Veauthier, G. Gaede, H. Radbruch et al. // Int. J. Mol. Sci. — 2015. — Vol. 16, № 7. — Р. 16514-16528.

The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis / L.C. Schairer, F.W. Foley, V. Zemon et al. // Mult. Scler. — 2014. — Vol. 20, № 5. — Р. 610-616.

Vitamin D and disease activity in multiple sclerosis before and during interferon treatment / K.I. Løken-Amsrud, T. Holmøy, S.J. Bakke // Neurology. — 2012. — Vol. 79, № 3. — Р. 267-273.

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression / A. Ascherio, K.L. Munger, R. White et al. // JAMA Neurol. — 2014. — Vol. 71, № 3. — Р. 306-314.

Кoutsouraki E. Epidemiology of multiple sclerosis in Europe: a review / E. Кoutsouraki, V. Costa, S. Baloyannis // Int. Rev. Psychiatry. — 2010. — Vol. 22, № 1. — Р. 2-13.




Copyright (c) 2016 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2020

 

   Seo анализ сайта